Sertraline Hydrochloride
- Product NDC
- 76420-779
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sertraline Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Asclemed USA, Inc.
- Application
- ANDA077206
- Marketing category
- ANDA
- Substance
- SERTRALINE HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 76420-779-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-779-01) | 2024-03-14 | | No | Historical |
| 76420-779-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-779-30) | 2024-03-14 | | No | Historical |
| 76420-779-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-779-60) | 2024-03-14 | | No | Historical |
| 76420-779-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-779-90) | 2024-03-14 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Sertraline Hydrochloride | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2025-02-12 | HUMAN PRESCRIPTION DRUG LABEL | 2 |